2-amino-1,3,4-thiadiazole has been researched along with Adenocarcinoma, Basal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albain, K; Benson, AB; Blough, R; French, S; Khandekar, JD; Kilton, L; Knop, RH; Lad, TE; Locker, GY | 1 |
| Asbury, RF; Blessing, JA; Hanjani, P; McGuire, WP; Mortel, R | 1 |
2 trial(s) available for 2-amino-1,3,4-thiadiazole and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Thiadiazoles | 1994 |
Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group.
Topics: Adenocarcinoma; Anemia; Antineoplastic Agents; Carcinoma; Drug Evaluation; Female; Humans; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Thiadiazoles; Uterine Neoplasms | 1990 |